• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT NC TREK CORONARY DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT NC TREK CORONARY DILATATION CATHETER Back to Search Results
Catalog Number 1012452-20
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 01/27/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).The device was received.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event or Problem Description
It was reported that the procedure was to treat a de novo lesion located in the mid right coronary artery (rca) with moderate tortuosity and moderate calcification.A 3.75 x 20 mm nc trek rx balloon dilatation catheter (bdc) was advanced to the lesion for post-dilatation and it crossed successfully.The nc trek was inflated once to an unknown pressure; however, it would not deflate using the indeflator.A 30 cc syringe was used to pull negative pressure several times and the balloon finally deflated completely.The bdc was removed from the anatomy without resistance.A new nc balloon was used to complete the procedure.There were no adverse patient effects or clinically significant delay in the procedure reported.No additional information was provided.
 
Additional Manufacturer Narrative
(b)(4).Evaluation summary: visual inspection was performed on the returned device.The complaint investigation determined the reported difficulty was determined to be related to manufacturing issues associated with the protective sheath.On march 14, 2017, abbott vascular decided to initiate a voluntary field action for some sizes and lots of the nc trek family of dilatation catheters for difficulty to remove sheath which may lead to inflation or deflation issues.Abbott vascular performed a comprehensive investigation which included device analysis, manufacturing evaluation and trend analysis.The root cause identification was complicated by the fact that users were describing multiple symptoms when reporting the complaints.To date, the frequency of worldwide reported events for difficulties removing the protective balloon sheath, inflation and deflation has reached an actionable limit, thus abbott vascular communicated the voluntary field action to the fda on march 17, 2017 [medwatch # 2024168-2017-02310].Corrective action has been implemented per site operating procedures.The product will continue to be trended.The abbott internal recall number is 2024168-3/14/2017-002-r.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC TREK CORONARY DILATATION CATHETER
Common Device Name
CORONARY DILATATION CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key6374757
Report Number2024168-2017-01735
Device Sequence Number773292
Product Code LOX
UDI-Device Identifier08717648152047
UDI-Public(01)08717648152047(17)190930(10)61018G1
Combination Product (Y/N)N
Initial Reporter StateMD
Initial Reporter CountryUS
PMA/510(K) Number
K110134
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Health Professional
Remedial Action Recall,Other
Type of Report Initial,Followup
Report Date (Section B) 03/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2019
Device Catalogue Number1012452-20
Device Lot Number61018G1
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer02/24/2017
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 02/07/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date03/02/2017
Supplement Report FDA Received Date03/30/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-